BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2022 6:17:12 AM | Browse: 290 | Download: 482
Publication Name World Journal of Clinical Oncology
Manuscript ID 65120
Country/Territory Serbia
Received
2021-02-28 10:32
Peer-Review Started
2021-02-28 10:46
To Make the First Decision
Return for Revision
2021-09-02 02:08
Revised
2021-09-16 11:33
Second Decision
2021-12-10 06:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-12-11 03:41
Articles in Press
2021-12-11 03:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-01-17 13:17
Publish the Manuscript Online
2022-01-22 06:17
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
Manuscript Source Invited Manuscript
All Author List Maja Popovic, Gorana Matovina-Brko, Masa Jovic and Lazar S Popovic
ORCID
Author(s) ORCID Number
Maja Popovic http://orcid.org/0000-0002-1679-7144
Gorana Matovina-Brko http://orcid.org/0000-0001-6491-5953
Masa Jovic http://orcid.org/0000-0001-9864-272X
Lazar S Popovic http://orcid.org/0000-0002-3278-6875
Funding Agency and Grant Number
Corresponding Author Lazar S Popovic, MD, PhD, Professor, Department for Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Department for Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Novi Sad 21000, Serbia. <email>lazar.popovic@mf.uns.ac.rs</email>, Sremska Kamenica 21204, Serbia. lazar.popovic@mf.uns.ac.rs
Key Words Renal cell carcinoma; Immunotherapy; Checkpoint inhibitors; Biomarkers; Tumor microenvironment; Programmed cell death 1 receptor
Core Tip Renal cell cancer is a highly immunogenic tumor infiltrated by cells, including CD8+ T lymphocytes, dendritic cells, natural killer cells and macrophages. This observation led to the design of new clinical trials in which patients were treated with immunotherapy. With the growing evidence that proangiogenic factors can have immunomodulatory effects on the host’s immune system, the idea of combining angiogenic drugs with immunotherapy has emerged, and new clinical trials have been designed. In the last few years, several therapeutic options have been approved (immunotherapy and immunotherapy/TKI) as first-line treatment for mccRCC.
Publish Date 2022-01-22 06:17
Citation Popovic M, Matovina-Brko G, Jovic M, Popovic LS. Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma. World J Clin Oncol 2022; 13(1): 28-38
URL https://www.wjgnet.com/2218-4333/full/v13/i1/28.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i1.28
Full Article (PDF) WJCO-13-28.pdf
Full Article (Word) WJCO-13-28.docx
Manuscript File 65120_Auto_Edited.docx
Answering Reviewers 65120-Answering reviewers.pdf
Audio Core Tip 65120-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 65120-Conflict-of-interest statement.pdf
Copyright License Agreement 65120-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 65120-Language certificate.pdf
Peer-review Report 65120-Peer-review(s).pdf
Scientific Misconduct Check 65120-Bing-Wang LL-2.png
Scientific Editor Work List 65120-Scientific editor work list.pdf